![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
CordenPharma Expands Early Clinical Peptide Manufacturing to Launch IND-Targeted Peptide API to Injectable Drug...
After an initial expansion of the CordenPharma Frankfurt site for non-GMP manufacturing in 2020, and...
Elsevier and Iktos partner to deliver an AI-driven synthetic chemistry platform for drug discovery
Elsevier, a global leader in information and data analytics, has signed a multi-year agreement with...
Charles River and Wheeler Bio Complete Agreement to Accelerate the Journey from Discovery and...
Charles River Laboratories International, Inc. announced a strategic agreement with Wheeler Bio, Inc., an antibody...
Azzur Group Expands Service Portfolio with Analytical Services for Advanced Therapeutics, Enhancing the Discovery...
There are currently more than 3,000 advanced therapies in the development pipeline globally, along with...
Resilience Expands Clinical and Commercial Drug Product Manufacturing Capabilities and Capacities
National Resilience, Inc. (Resilience), Expands Clinical and Commercial Drug Product Manufacturing Capabilities and CapacitiesNational Resilience,...
AbbVie and Tentarix Announce Collaboration to Develop Conditionally-Active, Multi-Specific Biologics for Oncology and Immunology
AbbVie Inc. and Tentarix Biotherapeutics today announced a multi-year collaboration focused on the discovery and...
Viatris Receives Global Minimized Risk of Antimicrobial Resistance Certification, Advancing its Commitment to Responsible...
Viatris Inc. a global healthcare company, announced that its Aurangabad, India, facility has received certification...
By Automating Traditional Methods, CROs Stand To Benefit
Big Pharma goes on to drive the demand for contract resource organizations- CROs by way...
Cresset Announces Global Collaboration with Enamine on New Virtual Screening Drug Discovery Technology
Cresset, an innovative provider of integrated in silico solutions for drug discovery announces a collaboration...
Drug Discovery Gets A Novel Approach With Biology-Driven AI
The quite hectic journey so as to bring a single new drug to the market...